New hope for kids with tough cancers: ponatinib trial launches
Disease control
Recruiting now
This study tests the drug ponatinib in children aged 1 to 18 with advanced leukemias, lymphomas, or solid tumors that have come back or not responded to standard treatment. The goal is to find safe doses and see if the drug can shrink tumors or improve blood counts. About 70 chil…
Phase: PHASE1, PHASE2 • Sponsor: Incyte Biosciences International Sàrl • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC